MedTrace Logo

Evaluating of New Screening Tool for Arthritis* in Psoriasis

NCT04277832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-01-14

No results posted yet for this study

Summary

This study evaluates a new screening tool for arthritis in psoriasis and compares its reliability with well-known screening tool (TOPAS 2).

Conditions

Interventions

DIAGNOSTIC_TEST

Questionary

All patients will answer two different questionary (TUPAST, TOPAS 2)

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Principal Investigators

  • Nahide MD Onsun, Prof · Bezmialem University

  • Begüm MD Güneş · Bezmialem University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2021-01-13
Completion
2021-01-13

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04277832 on ClinicalTrials.gov